We have previously shown that mast cells (MC) may act as accessory cells of bone resorption in a synchronized model of resorption. The aim of this study was to verify whether bone marrow MC accumulated during the phase of rapid osteopenia development in estrogen-deprived rats. Sprague-Dawley rats, 90 days old, were subjected to bilateral ovariectomy (OVX) or sham surgery (controls). Bone histomorphometry was performed in the proximal tibia metaphysis. Thirty days after surgery, serum estradiol had dropped (p < 0.002), and osteopenia was well established in the OVX rats (trabecular bone volume decreased by 69%, p < 0.0001). The indices of bone resorption were strongly modified: the number (p < 0.0001) and individual activity (p < 0.001) of the trabecular osteoclasts were prominently increased in the OVX rats. Ovariectomy resulted in a dramatic increase in the number of bone marrow MC (p < 0.0001), 97% of which were of the mucosal subtype. These results show that MC accumulate concomitantly with osteoclast generation in estrogen-deficient rats. Although the biological significance of this MC increase is unknown from these results, we hypothesize that MC might play a role in ovariectomy-induced bone loss similar to that they we previously proposed in a mechanically activated model of resorption.

Keywords:
Osteoporosis, Mast cell, Osteoclast, Estrogen deficiency, Ovariectomy, Rat
1.
Ammann, P., R. Rizzoli, J.P. Bonjour, S. Bourrin, J.M. Meyer P. Vassalli, I. Garcia (1997) Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99: 1699–1703.
2.
Bismar, H., I. Diel, R. Ziegler, J. Pfeilschifter (1995) Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80: 3351–3355.
3.
Chowdhury, M.H., C. Hamada, D.W. Dempster (1992) Effects of heparin on osteoclast activity. J Bone Miner Res 7: 771–777.
4.
Cohen-Solal, M.E., A.M. Graulet, M.A. Denne, J. Gueris, D. Baylink, M.C. de Vernejoul (1993) Peripheral monocyte culture supernatants of menopausal women can induce bone resorption – involvement of cytokines. J Clin Endocrinol Metab 77: 1648–1653.
5.
de Gennes, C., D. Kuntz, M.C. de Vernejoul (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop 279: 281–291.
6.
Dimitriadou, V., M.V. Buzzi, A. Moskowitz, T.C. Theoharides (1991) Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44: 97–112.
7.
Dobigny, C., J.L. Saffar (1991) Partial inhibition of bone resorption by disodium cromoglycate in a synchronized model of bone remodeling. Agents Actions 33: 326–329.
8.
Enerbäck, L. (1966) Mast cells in rat gastrointestinal mucosa. 2. Dye binding and metachromatic properties. Acta Pathol 66: 303–312.
9.
Enerbäck, L. (1986) Mast cell heterogeneity: The evolution of the concept of a specific mucosal mast cell; in Befus AD, J Bienenstock, JA Denburg (eds): Mast Cell Differentiation and Heterogeneity. New York, Raven Press, pp 1–25.
10.
Enerbäck, L., F. Aldenborg (1986) Histochemical differentiation of mast cell proteoglycans. J Histochem Cytochem 34: 1355.
11.
Erben, R.G., H. Weiser, F. Sinowatz, W.A. Rambeck, H. Zucker (1992) Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int 50: 228–236.
12.
Fallon, M.D., M.P. White, R.P. Craig, S.L. Teitelbaum (1983) Mast cell proliferation in postmenopausal osteoporosis. Calcif Tissue Int 35: 29–31.
13.
Frame, B., R.K. Nixon (1968) Bone marrow mast cells in osteoporosis and aging. N Engl J Med 269: 626–630.
14.
Franchi-Miller, C.; J.L. Saffar (1995) The 5-lipoxygenase inhibitor BWA4C impairs osteoclastic resorption in a synchronized model of bone remodeling. Bone 17: 185–191.
15.
Frost, H.M., W.S.S. Jee (1992) On the rat model of human osteopenias and osteoporoses. Bone Miner 18: 227–236.
16.
Grardel, B., B. Flautre, B. Sutter, J. Duriez, P. Hardouin (1991) Etude des mastocytes sur 1298 biopsies osseuses: Relations entre mastocytes et ostéoporose. Rev Rhum 58: 759–761.
17.
Harvey, J.A., H.C. Anderson, D. Borek, D. Morris, B.P. Lukert (1989) Osteoporosis associated with mastocytosis confined to bone: Report of two cases. Bone 10: 237–241.
18.
Jilka, R.L., G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, S.C. Manolagas (1992) Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 87–91.
19.
Johnson, R.A., B.F. Boyce, G.R. Mundy, G.D. Roodman (1989) Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124: 1424–1427.
20.
Kalu, D.N. (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15: 175–192.
21.
Kimble, R.B., R. Kitazawa, J.L. Vannice, R. Pacifici (1994) Persistent bone-sparing effect of interleukin-1 receptor antagonist: A hypothesis on the role of IL-1 in ovariectomy-induced bone loss. Calcif Tissue Int 55: 260–265.
22.
Lerner, U.H. (1996) Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. J Bone Miner Res 11: 1628–1636.
23.
Liggett, W., N. Shevde, P. Anklesaria, S. Sohoni, J. Greenberger, J. Glowacki (1993) Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells. Stem Cells 11: 398– 411.
24.
Mano, H., T. Yuasa, T. Kameda, K. Miyazawa, Y. Nakamura, M. Shiokawa, Y. Mori, T. Yamada, K. Miyata, H. Shindo, H. Azuma, Y. Hakeda, M. Kumegawa (1996) Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223: 637–642.
25.
McMillan, P.J., R.A. Dewri, E.E. Joseph, R.L. Schultz, L.J. Deftos (1989) Rapid changes of light microscopic indices of osteoclast-bone relationships correlated with electron microscopy. Calcif Tissue Res 44: 399–405.
26.
Metcalfe, D.D., D. Baram, Y.A. Mekori (1997) Mast cells. Physiol Rev 77: 1033–1079.
27.
Minkin, C. (1982) Bone acid phosphatase: Tartrate resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Res 34: 285–290.
28.
Muir, J.M., M. Andrew, J. Hirsh, J.I. Weitz, E. Young, P. Deschamps, S.G. Shaughnessy (1996) Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood 88: 1314–1320.
29.
Muir, J.M., J. Hirsh, J.I. Weitz, M. Andrew, E. Young, S.G. Shaughnessy (1997) A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats. Blood 89: 3236–3242.
30.
Peck, W.A., W.L. Woods (1988) The cells of bone; in Riggs BL, LJ Melton (eds): Osteoporosis: Etiology, Diagnosis and Management. New York, Raven Press, pp 1–44.
31.
Povolny, B.T., M.Y. Lee (19939 The role of recombinant human M-CSF, IL-3, GM-CSF and calcitriol in clonal development of osteoclast precursors in primate bone marrow. Exp Hematol 21: 532–537.
32.
Robinson, J.A., B.L. Riggs, T.C. Spelsberg, M.j. Oursler (1996) Osteoclasts and transforming growth factor-β: Estrogen-mediated isoform-specific regulation of production. Endocrinology 137: 615–621.
33.
Saffar, J.L., M. Klapisz-Wolikow (1990) Changes in mast cell number during the activation phase of induced synchronized remodeling sequence in rat. Bone 11: 369–372.
34.
Silberstein, R., M. Melnick, G. Greenberg, C. Minkin (1991) Bone remodeling in W/Wv mast cell deficient mice. Bone 12: 227–236.
35.
Theoharides, T.C. (1996) The mast cell: A neuroimmunoendocrine master player. Int J Tiss Reac 18: 1–21.
36.
Thompson, D.D., H.A. Simmons, C.M. Pirie, H.Z. Ke (1995) FDA guidelines and animals models for osteoporosis. Bone 17: 125S–133S.
37.
Waynforth, H.B. (1980) Experimental and Surgical Techniques in the Rat. New York, Academic Press.
38.
Wronski, T.J., M. Cintrom, L.M. Dann (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43: 179–183.
39.
Wronski, T.J., L.M. Dann, K.S. Scott, M. Cintrom (1989) Long term effects of ovariectomy and aging on rat skeleton. Calcif Tissue Int 45: 360–366.
40.
Wronski, T.J., C.F. Yen (1991) The ovariectomized rats as an animal model for postmenopausal bone loss. Cells Mater Suppl. 1: 69–74.
41.
Yamagata, T., H. Saito, O. Habuchi, S. Suzuki (1968) Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 10: 1523–1535.
42.
Zheng, M.H., T.T.A. Lau, R. Prince, A. Criddle, S. Wysocki, M. Beilharz, J.M. Papadimitriou, D.J. Wood (1995) 17-β-Estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats. Calcif Tissue Int 56: 166–169.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.